Retour aux projets

18022.1 PFLS-LS

Structure-based drug discovery with thermostabilized G protein-coupled receptors (GPCR)

Résumé

Structure-based drug discovery with thermostabilized G protein-coupled receptors (GPCR)

Textes supplémentaires

Abstract

G protein-coupled receptors (GPCRs) are the single largest class of validated drug targets. Current|approaches in GPCR drug development led to significant failure rates and no successful novel chemical|entities (NCEs) to multiple high-value GPCR targets. G7 Therapeutics in collaboration with the University of|Zurich will apply its CHESS technology to identify and visualize the interaction of NCEs with GPCR targets of|clinical importance in order to create better medication.

Participants

Carlo Bertozzi

Wirtschaftspartner

carlo.bertozzi@g7therapeutics.com

Heptares Therapeutics Zurich AG Carlo Bertozzi Grabenstrasse 11a 8952 Schlieren ZH CH

Andreas Plückthun

Kontaktperson

plueckthun@bioc.uzh.ch

Universität Zürich Organisch-chemisches Institut Andreas Plückthun Winterthurerstrasse 190 8057 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-02-29
Date de fin
2019-02-28
Coûts totaux approuvés
CHF 886937.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%